AVTX Shares Outstanding History



Below is a table of the AVTX shares outstanding history going back to 7/30/2021:

Date AVTX Shares Outstanding
7/30/202133336
11/5/202138999
2/28/202239165
5/2/202239165
8/2/202239225
11/3/202239225
3/24/202355002
5/1/202355002
8/2/202384373
11/7/2023801593

Also see: AVTX Market Cap History
AVTX YTD Return
AVTX Historical Shares Outstanding:
+304.88% CAGR
AVTX Historical Shares Outstanding: +304.88% CAGR

Mouse over chart for data details
7/30/2021 ...11/7/2023
Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. Co.'s clinical-stage pipeline include: AVTX-002, which is a fully human monoclonal antibody, directed against human LIGHT (Lymphotoxin-like, exhibits Inducible expression, and competes with HSV Glycoprotein D for Herpesvirus Entry Mediator, a receptor expressed by T lymphocytes) being developed for the treatment of non-eosinophilic asthma; AVTX-008, which is a fully human B and T Lymphocyte Attenuator agonist fusion protein; and AVTX-803, which is a fucose replacement for leukocyte adhesion deficiency type II. We show 10 historical shares outstanding datapoints in our coverage of AVTX's shares outstanding history.

Understanding the changing numbers of AVTX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like AVTX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching AVTX by allowing them to research AVTX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree AVTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Avalo Therapeutics (AVTX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

AVXL Shares Outstanding History
AWH Shares Outstanding History
AXDX Shares Outstanding History
AXGN Shares Outstanding History
AXGT Shares Outstanding History
AXLA Shares Outstanding History
AXNX Shares Outstanding History
AXSM Shares Outstanding History
AYLA Shares Outstanding History
AYTU Shares Outstanding History
More Healthcare companies »

 

AVTX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.